Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Leap Therapeutics Inc LPTX

Healthcare Biotechnology
Leap Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on developing targeted and immuno-oncology therapeutics. Its advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-related protein 1 (DKK1) protein. DKK1 is also a modulator of CKAP4/PI3K/AKT signaling. DKN-01 is being developed in patients with esophagogastric, gynecologic... see more

Recent & Breaking News (NDAQ:LPTX)

Leap Therapeutics to Present at Two October Conferences

PR Newswire September 25, 2018

Leap Therapeutics to Participate in the H.C. Wainwright 20th Annual Global Investment Conference

PR Newswire August 30, 2018

Recent Analysis Shows Leap Therapeutics, Gardner Denver, Medical Transcription Billing, CarGurus, Liberty Media, and Quorum Health Market Influences — Renewed Outlook, Key Drivers of Growth

GlobeNewswire August 22, 2018

Leap Therapeutics Reports Second Quarter 2018 Business Update and Financial Results

GlobeNewswire August 8, 2018

Leap Therapeutics Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Combination of TRX518, Avelumab, and Chemotherapy in Advanced Solid Tumors

GlobeNewswire July 23, 2018

Analysis: Positioning to Benefit within Ruth's Hospitality Group, S&P Global, Shaw Communications, Leap Therapeutics, Red Hat, and Welltower — Research Highlights Growth, Revenue, and Consolidated Results

GlobeNewswire June 13, 2018

Leap Therapeutics to Present at the 2018 JMP Securities Life Sciences Conference

GlobeNewswire June 13, 2018

Leap Therapeutics Reports First Quarter 2018 Financial Results

GlobeNewswire May 11, 2018

Leap Therapeutics Presents Nonclinical and Clinical Data on DKN-01 at AACR 2018 Annual Meeting

GlobeNewswire April 16, 2018

New Research Coverage Highlights Holly Energy Partners, Liberty Property Trust, Fair Isaac, 58, Cousins Properties, and Leap Therapeutics — Consolidated Revenues, Company Growth, and Expectations for 2018

GlobeNewswire March 28, 2018

Leap Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire March 27, 2018

Leap Therapeutics Announces Pricing of $14 Million Public Offering of Common Stock

GlobeNewswire March 23, 2018

A Peek Into The Markets: U.S. Stock Futures Signal Lower Start On Wall Street

Benzinga.com  March 23, 2018

8 Stocks To Watch For March 23, 2018

Benzinga.com  March 23, 2018

Leap Therapeutics Announces Proposed Public Offering of Common Stock

GlobeNewswire March 22, 2018

Leap Therapeutics to Present at the 2018 Needham & Company 17th Annual Healthcare Conference

GlobeNewswire March 21, 2018

Leap Therapeutics Provides DKN-01 Program Update and Announces Scientific Presentations at AACR Annual Meeting

GlobeNewswire March 14, 2018

Leap Therapeutics to Present at 2018 Barclays Global Healthcare Conference

GlobeNewswire March 7, 2018

Leap Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Announces Date of its Annual Meeting of Stockholders

GlobeNewswire February 23, 2018

Leap Therapeutics to Present at the 20th Annual BIO CEO & Investor Conference

GlobeNewswire February 6, 2018